We are committed to helping you achieve lasting weight loss results through the proper use of these treatments, supporting you every step of the way
Without these supports, GLP-1 patients are at higher risk of muscle loss, nutrient deficiencies, and weight regain after stopping the medication
Semaglutide and other GLP-1 agonistsmedications that bind to GLP-1 receptors and mimic their effectsare currently used as treatments for diabetes and obesity
Signs of semaglutide depression usually include more persistent sadness, loss of interest in activities, or trouble concentrating beyond what youd expect from dieting alone
Specifically, the following signals were detected: exenatide (N = 506, ROR = 1.88, 95% CI = 1.722.05, PRR = 1.88, 2 = 205.06, IC = 0.90, IC025 = 0.77), liraglutide (N = 491, ROR = 6.75, 95% CI = 6.177.38, PRR = 6.71, 2 = 2367.04, IC = 2.74, IC025 = 2.59), semaglutide (N = 473, ROR = 5.74, 95% CI = 5.246.28, PRR = 5.71, 2 = 1824.26, IC = 2.50, IC025 = 2.36), dulaglutide (N = 189, ROR = 1.29, 95% CI = 1.121.49, PRR = 1.29, 2 = 12.42, IC = 0.37, IC025 = 0.16), tirzepatide (N = 159, ROR = 1.98, 95% CI = 1.702.32, PRR = 1.98, 2 = 76.95, IC = 0.98, IC025 = 0.75)
Both individual and class action cases are being filed in multiple states, alleging that Novo Nordisk, the manufacturer of Ozempic, failed to adequately warn patients and healthcare providers about the potential risk of serious vision complications